Skip to main content

and
  1. No Access

    Article

    Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment

     The clinical significance of the multidrug resistance (MDR 1) gene phenotype was investigated in newly diagnosed AML and was compared with other clinical and biological prognostic factors in patients who receive...

    M. Hunault, D. Zhou, A. Delmer, S. Ramond, F. Viguié, M. Cadiou in Annals of Hematology (1997)

  2. No Access

    Article

    Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype

    The blastic variant (BV) form of mantle cell lymphoma (MCL) is considered to be a very aggressive subtype of non-Hodgkin's lymphoma (NHL). In order to determine its clinico-biological features and response to ...

    M Bernard, R Gressin, F Lefrère, B Drénou, B Branger, S Caulet-Maugendre in Leukemia (2001)

  3. No Access

    Article

    Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin

    P Chevallier, T Prebet, A Pigneux, M Hunault, J Delaunay, F Perry, L Lode in Leukemia (2010)

  4. No Access

    Article

    A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

    A simplified prognostic score is presented based on the multivariate analysis of 138 refractory/relapsed acute myeloid leukaemia (AML) patients (median age 55 years, range: 19–70) receiving a combination of in...

    P Chevallier, M Labopin, P Turlure, T Prebet, A Pigneux, M Hunault in Leukemia (2011)

  5. No Access

    Article

    Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia

    C Récher, M C Béné, B Lioure, A Pigneux, N Vey, J Delaunay, I Luquet, M Hunault in Leukemia (2014)